[G03XB02, ulipristal, Ulipristal may increase the thrombogenic activities of Tranexamic acid.]
[B01AD01, streptokinase, The therapeutic efficacy of Tranexamic acid can be decreased when used in combination with Streptokinase.]
[B02AB01, aprotinin, Tranexamic acid may increase the thrombogenic activities of Aprotinin.]
[L01XF01, tretinoin, The risk or severity of hypercoagulability can be increased when Tretinoin is combined with Tranexamic acid.]
[B01AD04, urokinase, The therapeutic efficacy of Tranexamic acid can be decreased when used in combination with Urokinase.]
[G03AC10, drospirenone, Drospirenone may increase the thrombogenic activities of Tranexamic acid.]
[G03AC08, etonogestrel, Etonogestrel may increase the thrombogenic activities of Tranexamic acid.]
[B02AA03, 4-aminomethylbenzoic acid, Tranexamic acid may increase the thrombogenic activities of Aminomethylbenzoic acid.]
[B02BX06, emicizumab, Tranexamic acid may increase the thrombogenic activities of Emicizumab.]
[V03AB38, andexanet alfa, Tranexamic acid may increase the thrombogenic activities of Andexanet alfa.]
[G03DB05, demegestone, Demegestone may increase the thrombogenic activities of Tranexamic acid.]
[G03AC09, desogestrel, Desogestrel may increase the thrombogenic activities of Tranexamic acid.]
[G03DB08, dienogest, Dienogest may increase the thrombogenic activities of Tranexamic acid.]
[G03DC06, ethynodiol, Etynodiol may increase the thrombogenic activities of Tranexamic acid.]
[B01AD11, tenecteplase, The therapeutic efficacy of Tranexamic acid can be decreased when used in combination with Tenecteplase.]
[B02BD03, anti-inhibitor coagulant complex, Tranexamic acid may increase the thrombogenic activities of Factor IX Complex (Human).]
[G03DB04, nomegestrol, Nomegestrol may increase the thrombogenic activities of Tranexamic acid.]
[L02AA01, diethylstilbestrol, Diethylstilbestrol may increase the thrombogenic activities of Tranexamic acid.]
[B01AD03, anistreplase, The therapeutic efficacy of Tranexamic acid can be decreased when used in combination with Anistreplase.]
[G03CA03, estradiol, Estradiol may increase the thrombogenic activities of Tranexamic acid.]
[L02AA03, ethinyl estradiol, Ethinylestradiol may increase the thrombogenic activities of Tranexamic acid.]
[B02BD08, factor VIIa, Tranexamic acid may increase the thrombogenic activities of Coagulation factor VIIa Recombinant Human.]
[B02BD14, antihemophilic factor, porcine B-domain truncated recombinant, Tranexamic acid may increase the thrombogenic activities of Susoctocog alfa.]
[B02BD11, coagulation factor XIII a-subunit (recombinant), Tranexamic acid may increase the thrombogenic activities of Catridecacog.]
[B02BD07, factor XIII, Tranexamic acid may increase the thrombogenic activities of Factor XIII (human).]
[B02BB01, fibrinogen, human, The therapeutic efficacy of Fibrinogen human can be increased when used in combination with Tranexamic acid.]
[G03XA02, gestrinone, Gestrinone may increase the thrombogenic activities of Tranexamic acid.]
[B02AB02, alpha 1-antitrypsin, Alpha-1-proteinase inhibitor may increase the thrombogenic activities of Tranexamic acid.]
[S02AA06, hydrogen peroxide, Tranexamic acid may increase the thrombogenic activities of Hydrogen peroxide.]
[C04AF01, kininogenase, Tranexamic acid may increase the thrombogenic activities of Kallidinogenase.]
[G03AD01, levonorgestrel, Levonorgestrel may increase the thrombogenic activities of Tranexamic acid.]
[G03DC03, lynestrenol, Lynestrenol may increase the thrombogenic activities of Tranexamic acid.]
[B02BA02, vitamin K3, Menadione may increase the thrombogenic activities of Tranexamic acid.]
[G03XB01, mifepristone, Mifepristone may increase the thrombogenic activities of Tranexamic acid.]
[G03DC02, norethindrone, Norethisterone may increase the thrombogenic activities of Tranexamic acid.]
[G03AC07, norgestrienone, Norgestrienone may increase the thrombogenic activities of Tranexamic acid.]
[B01AD07, reteplase, The therapeutic efficacy of Tranexamic acid can be decreased when used in combination with Reteplase.]
[G03DB06, chlormadinone, Chlormadinone may increase the thrombogenic activities of Tranexamic acid.]
[S01XA13, alteplase, The therapeutic efficacy of Tranexamic acid can be decreased when used in combination with Alteplase.]
[G03DA04, progesterone, Progesterone may increase the thrombogenic activities of Tranexamic acid.]
[B02AA01, 6-aminocaproic acid, Tranexamic acid may increase the thrombogenic activities of Aminocaproic acid.]
